Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer
Abstract A significant subset of patients with metastatic breast cancer develops brain metastasis. As efficacy of systemic therapies has improved and patients live longer with metastatic breast cancer, the incidence of breast cancer brain metastases has increased. Brain metastases pose a clinical ch...
Main Authors: | Stefania Morganti, Heather A. Parsons, Nancy U. Lin, Albert Grinshpun |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-023-00550-1 |
Similar Items
-
Management of Brain and Leptomeningeal Metastases from Breast Cancer
by: Alessia Pellerino, et al.
Published: (2020-11-01) -
Editorial: Brain and leptomeningeal metastases in lung cancer
by: Tiziana Vavalà, et al.
Published: (2023-01-01) -
Comparison of the diagnostic value of liquid biopsy in leptomeningeal metastases: A systematic review and meta-analysis
by: Hanbin Wang, et al.
Published: (2022-12-01) -
Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases
by: Mariam Lotfy Khaled, et al.
Published: (2023-03-01) -
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan
by: Laura Alder, et al.
Published: (2023-03-01)